Opening Recap Market Pulse: Nifty drifts lower into the FY26 finish line as West Asia war fears push crude above $108 and foreign inflows evaporate. U.S. indexes chop around their 200-day moving average, with swing traders eyeing...
Latest articles
OGI’s Big Move: Shareholder Approval for Sanity Group!
Overview – A Transformative Cross-Border Acquisition Organigram Global Inc. (NASDAQ/TSX: OGI), a Canadian licensed cannabis producer, has won shareholder approval to acquire Germany’s Sanity Group GmbH in a major cross-border...
Bearish Markets and Bullish Swing Trade Picks
Market Pulse: Global energy jitters and currency slides stamped a bearish mood as benchmarks skidded through a fifth straight weekly drop after Friday’s sell-off. Key Movers: Crude ripped past $108 on Iran tensions, the rupee...
CORT ALERT: Class Action Looms After FDA Rejection!
Company Overview Corcept Therapeutics Incorporated (NASDAQ: CORT) is a commercial-stage biopharmaceutical company focused on developing drugs that modulate the effects of cortisol, a stress hormone (intellectia.ai). Its flagship...
Markets Slide on Geopolitics: ACME Solar, XRP Trade Alerts
Opening Recap Market Pulse Equities across India drifted lower for a fifth straight week as Middle East tensions sent traders into selling mode, with benchmark indices not offering any respite. Key Movers Technical setups in ACME...
CORT ALERT: Class Action Looms After FDA Rejection!
Corcept Therapeutics (NASDAQ: CORT) faces intense scrutiny after the FDA’s surprise rejection of its lead drug candidate, relacorilant, sent the stock crashing and prompted a securities class action. On December 31, 2025, Corcept...
IDE: FDA Filing for Glucotrack Could Drive 2025 Gains!
Company Overview & FDA IDE Catalyst GlucoTrack, Inc. (NASDAQ: GCTK) is a micro-cap medical technology company developing a fully implantable continuous blood glucose monitor (CBGM) for people with diabetes (www...
EDSA: Edesa Biotech’s Vitiligo Program Enrollment in 2026!
Edesa Biotech, Inc. (NASDAQ: EDSA) is a clinical-stage biopharmaceutical company focused on developing novel, host-directed therapies for immune-mediated and inflammatory diseases (www.edesabiotech.com) (www.biospace.com). The...
Bitcoin Slumps, Gold Soars Amid Ceasefire Hopes
Daily Financial Update Good morning, traders—Thursday, March 26, 2026. Let’s chop through the noise: here’s what moved markets yesterday and what to watch today. Market Pulse Bitcoin dipped to test its 50-day trend line in the...
BSX: Urgent Action Needed for Investors Before Deadline!
Overview and Recent Performance Boston Scientific Corporation (NYSE: BSX) is a leading medical device manufacturer with products ranging from stents and catheters to pacemakers and heart implants (www.kiplinger.com). The company...
